FIELD: medicine. SUBSTANCE: method involves applying combined treatment including 1.3 mcm wavelength laser radiation exposure of prelimbic region at a dose of 0.2 J/cm2 during 2 min and direct action applied to retina lesion region with 10-6 W/cm2 during 2 min and laser field being equal to 20 deg of visual angle. EFFECT: enhanced effectiveness of treatment.
Title | Year | Author | Number |
---|---|---|---|
DEVICE FOR APPLYING LASER THERAPY IN OPHTHALMOLOGY | 1998 |
|
RU2204971C2 |
DEVICE FOR LASER THERAPY IN OPHTHALMOLOGY | 1992 |
|
RU2092140C1 |
DEVICE FOR TREATING AMBLYOPIA | 0 |
|
SU1827157A1 |
METHOD FOR TREATING LESIONS OF VISUAL ANALYZER | 2004 |
|
RU2264241C2 |
METHOD FOR TRANSCHOROID INTRODUCTION OF MEDICINAL PREPARATIONS AT DYSTROPHIC DISEASES OF POSTERIOR OCULAR DEPARTMENT | 2005 |
|
RU2281735C1 |
METHOD OF DIFFERENTIATED APPROACH TO SURGICAL TREATMENT OF CHRONIC FORM OF CENTRAL SEROUS CHORIORETINOPATHY | 2024 |
|
RU2823160C1 |
DEVICE FOR APPLYING OPHTHALMOLOGICAL LASER THERAPY | 1998 |
|
RU2204365C2 |
METHOD FOR TREATING THE CASES OF AMBLYOPIA | 2002 |
|
RU2205042C1 |
METHOD FOR DIAGNOSING CHANGES IN ORGAN OF VISION IN CASE OF CONGENITAL MYOPIA | 0 |
|
SU1766360A1 |
AGENT RECOVERING RETINA EYE FUNCTION | 1993 |
|
RU2073518C1 |
Authors
Dates
1997-12-10—Published
1994-10-06—Filed